Actively Recruiting

Phase 4
Age: 20Years +
All Genders
NCT06846411

The EMPA-FIT Study

Led by Seoul National University Bundang Hospital · Updated on 2025-02-26

46

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This multicenter, open-label, prospective study randomized 46 drug-naïve adults with T2D (HbA1c 6.5%-10.0%) to receive empagliflozin (10 mg/day) or metformin (1,000 mg/day) for 12 weeks.

CONDITIONS

Official Title

The EMPA-FIT Study

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have type 2 diabetes with HbA1c between 6.5% and 10.0%
  • Are between 20 and 75 years old
  • Have not taken any anti-diabetic medications for at least 8 weeks prior to screening
Not Eligible

You will not qualify if you...

  • Body mass index (BMI) less than 18.5 kg/m² or 40 kg/m² or higher
  • Clinically significant liver problems such as cirrhosis, portal hypertension, or chronic active hepatitis
  • History of acute cardiovascular events, including coronary artery disease, stroke, or peripheral arterial disease, within 2 months before enrollment
  • Chronic kidney disease with eGFR less than 60 mL/min/1.73 m² or end-stage renal disease with eGFR less than 15 mL/min/1.73 m² or on dialysis
  • Uncontrolled high blood pressure (160/100 mmHg or higher)
  • New York Heart Association class III or IV heart failure
  • Use of oral corticosteroids for more than 30 consecutive days
  • History of cancer (except basal cell carcinoma) within the past 5 years
  • Very high blood fat levels (triglycerides over 1000 mg/dL or LDL cholesterol over 250 mg/dL)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

SNUBH

Seongnam, South Korea

Actively Recruiting

Loading map...

Research Team

J

Ji Young Byun Administrative staff, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The EMPA-FIT Study | DecenTrialz